Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

CD4(+) T-cell recovery after initiation of antiretroviral therapy in a resource-limited setting: a prospective cohort analysis.

Kanters S, Nachega J, Funk A, Mukasa B, Montaner JS, Ford N, Bucher HC, Mills EJ.

Antivir Ther. 2014;19(1):31-9. doi: 10.3851/IMP2670. Epub 2013 Aug 20.

PMID:
23963170
2.

Risk of tuberculosis after antiretroviral treatment initiation: a comparison between efavirenz and nevirapine using inverse probability weighting.

Hermans SM, Manabe YC, Kiragga AN, Hoepelman AI, Lange JM, van Leth F.

Antivir Ther. 2013;18(4):615-22. doi: 10.3851/IMP2525. Epub 2013 Feb 19.

PMID:
23423604
3.

Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy.

Hunt PW, Cao HL, Muzoora C, Ssewanyana I, Bennett J, Emenyonu N, Kembabazi A, Neilands TB, Bangsberg DR, Deeks SG, Martin JN.

AIDS. 2011 Nov 13;25(17):2123-31. doi: 10.1097/QAD.0b013e32834c4ac1.

4.

Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies.

Nash D, Katyal M, Brinkhof MW, Keiser O, May M, Hughes R, Dabis F, Wood R, Sprinz E, Schechter M, Egger M; ART-LINC Collaboration of IeDEA.

AIDS. 2008 Nov 12;22(17):2291-302. doi: 10.1097/QAD.0b013e3283121ca9.

5.

Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count.

García F, de Lazzari E, Plana M, Castro P, Mestre G, Nomdedeu M, Fumero E, Martínez E, Mallolas J, Blanco JL, Miró JM, Pumarola T, Gallart T, Gatell JM.

J Acquir Immune Defic Syndr. 2004 Jun 1;36(2):702-13.

PMID:
15167289
6.

Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.

Goicoechea M, Smith DM, Liu L, May S, Tenorio AR, Ignacio CC, Landay A, Haubrich R.

J Infect Dis. 2006 Jul 1;194(1):29-37. Epub 2006 May 18.

7.

An optimal body mass index range associated with improved immune reconstitution among HIV-infected adults initiating antiretroviral therapy.

Koethe JR, Jenkins CA, Shepherd BE, Stinnette SE, Sterling TR.

Clin Infect Dis. 2011 Nov;53(9):952-60. doi: 10.1093/cid/cir606. Epub 2011 Sep 26.

8.

Initiating antiretroviral therapy when presenting with higher CD4 cell counts results in reduced loss to follow-up in a resource-limited setting.

Clouse K, Pettifor A, Maskew M, Bassett J, Van Rie A, Gay C, Behets F, Sanne I, Fox MP.

AIDS. 2013 Feb 20;27(4):645-50. doi: 10.1097/QAD.0b013e32835c12f9.

9.

Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.

Kaufmann GR, Furrer H, Ledergerber B, Perrin L, Opravil M, Vernazza P, Cavassini M, Bernasconi E, Rickenbach M, Hirschel B, Battegay M; Swiss HIV Cohort Study.

Clin Infect Dis. 2005 Aug 1;41(3):361-72. Epub 2005 Jun 24.

10.

Early immunologic failure is associated with early mortality among advanced HIV-infected adults initiating antiretroviral therapy with active tuberculosis.

Ravimohan S, Tamuhla N, Steenhoff AP, Letlhogile R, Makutu DK, Nfanyana K, Rantleru T, Tierney A, Nkakana K, Schwartz AB, Gross R, Macgregor RR, Bellamy SL, Frank I, Weissman D, Bisson GP.

J Infect Dis. 2013 Dec 1;208(11):1784-93. doi: 10.1093/infdis/jit368. Epub 2013 Aug 1.

11.

A prospective study of highly active antiretroviral therapy in Indian human immunodeficiency virus positive patients.

Rajesh R, Vidyasagar S, Varma DM, Naik A, Hegde BM, Guddattu V, Kamath A.

Int J Risk Saf Med. 2013 Jan 1;25(1):53-65. doi: 10.3233/JRS-130580.

PMID:
23442298
12.

Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa.

Hermans SM, Kiragga AN, Schaefer P, Kambugu A, Hoepelman AI, Manabe YC.

PLoS One. 2010 May 7;5(5):e10527. doi: 10.1371/journal.pone.0010527.

13.
14.

Long-term increase in CD4+ T-cell counts during combination antiretroviral therapy for HIV-1 infection.

Lok JJ, Bosch RJ, Benson CA, Collier AC, Robbins GK, Shafer RW, Hughes MD; ALLRT team.

AIDS. 2010 Jul 31;24(12):1867-76. doi: 10.1097/QAD.0b013e32833adbcf.

15.

Treatment initiation with zidovudine-containing potent antiretroviral therapy impairs CD4 cell count recovery but not clinical efficacy.

Huttner AC, Kaufmann GR, Battegay M, Weber R, Opravil M.

AIDS. 2007 May 11;21(8):939-46.

PMID:
17457087
16.

The extent of HIV-1-related immunodeficiency and age predict the long-term CD4 T lymphocyte response to potent antiretroviral therapy.

Kaufmann GR, Bloch M, Finlayson R, Zaunders J, Smith D, Cooper DA.

AIDS. 2002 Feb 15;16(3):359-67.

PMID:
11834947
17.

Association between age at antiretroviral therapy initiation and 24-month immune response in West-African HIV-infected children.

Desmonde S, Dicko F, Koueta F, Eboua T, Balestre E, Amani-Bosse C, Aka EA, Lawson-Evi K, Amorissani-Folquet M, Kouakou K, Koumakpai S, Renner L, Signaté Sy H, Leroy V; IeDEA West Africa Paediatric Collaboration.

AIDS. 2014 Jul 17;28(11):1645-55. doi: 10.1097/QAD.0000000000000272.

18.

Predicting the magnitude of short-term CD4+ T-cell recovery in HIV-infected patients during first-line highly active antiretroviral therapy.

Castagna A, Galli L, Torti C, D'Arminio Monforte A, Mussini C, Antinori A, Cozzi-Lepri A, Ladisa N, De Luca A, Seminari E, Gianotti N, Lazzarin A.

Antivir Ther. 2010;15(2):165-75. doi: 10.3851/IMP1513.

PMID:
20386071
19.

Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy.

Le T, Wright EJ, Smith DM, He W, Catano G, Okulicz JF, Young JA, Clark RA, Richman DD, Little SJ, Ahuja SK.

N Engl J Med. 2013 Jan 17;368(3):218-30. doi: 10.1056/NEJMoa1110187.

20.

Treatment outcomes among HIV-1 and HIV-2 infected children initiating antiretroviral therapy in a concentrated low prevalence setting in West Africa.

Okomo U, Togun T, Oko F, Peterson K, Townend J, Peterson I, Jaye A.

BMC Pediatr. 2012 Jul 8;12:95. doi: 10.1186/1471-2431-12-95.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk